Commentary

TPG takes advantage of high valuations; KKR’s State of Play a must-read for dealmakers

TPG’s earnings report, out this morning, underscores that it’s a good time for exits; KKR’s recent State of Play report by partner Henry McVey is loaded with analysis.

Beware: cracks appearing on the deal front

Is stress, or even distress, inevitable for portfolios? Here’s what to look for – and how to change course before it’s too late.

Spotlight on Thoma Bravo’s Circle CVI deal; vote of confidence for Vista

Thoma Bravo's investment in Circle Cardiovascular Imaging goes under the microscope.

RSM identifies trends to watch; packaging deals heat up; updates on FTV and Knox Lane

FTV and Knox Lane wrap up funds.

InTandem and the creation of its Vivo Infusion platform, Iconiq is back with its next growth flagship

Iconiq goes back to market with a new fund.

L Catterton buys Len the Plumber; Gridiron tops new ranking of mid-market PE firms

TSCP sells Len the Plumber to L Catterton.

Thoma Bravo takes Anaplan private for $10.7bn; Clearlake, Motive acquire BETA+ from LSEG

Berkshire Hathaway is buying Alleghany for $11.6 billion.

TA backs Veracode, as PE-backed cybersecurity deals heat up; plus, spotlight on Acon’s Anjali Jolly

PE investing in cybersecurity companies are on the rise.

'Superb' earnings drove EQT’s price for BPEA; plus HGGC’s Fullscript buys Emerson

HGGC-backed Fullscript acquires Emerson Ecologics and the spotlight continues on top women in private equity.

Deerfield's Jim Flynn on healthcare investing, ‘LPs are drinking from a firehose’ in PE fundraising

Deerfield's Jim Flynn discusses healthcare investing.